Navigation Links
Antidepressants May Prevent Depression After Stroke
Date:5/27/2008

Problem-solving therapy could also make a difference, study shows

TUESDAY, May 27 (HealthDay News) -- Stroke victims often succumb to depression in the months following their attack, but taking an antidepressant may reduce that risk, a new study finds.

To a lesser degree, problem-solving therapy also lowers the chances of depression among stroke victims.

More than half of the 700,000 people who will have a stroke in the United States this year will develop depression. Depression after stroke is associated with difficulty in recovering the activities of daily life and with an increased risk of death, University of Iowa researchers said in their report.

"The study highlights post-stroke depression, an important clinical problem," said Dr. Larry B. Goldstein, director of the Duke Center for Cerebrovascular Disease at Duke University Medical Center.

"A previous systematic review found that there was insufficient evidence from randomized trials to support the routine use of antidepressants for the prevention of depression or to improve recovery and pointed out the need for further study," Goldstein said. "This small trial provides evidence that pharmacological treatment might decrease the occurrence of post-stroke depression, and that there may be a role for behavioral intervention as well."

The report is published in the May 28 issue of the Journal of the American Medical Association.

In the study, Dr. Robert G. Robinson and his colleagues looked at the effectiveness of the antidepressant Lexapro or problem-solving therapy in preventing depression among people recovering from strokes.

Within three months of a stroke, 176 patients were randomly assigned to receive Lexapro (escitalopram), problem-solving therapy or a placebo. Problem-solving consisted of six sessions, plus an additional six reinforcement sessions, where patients were asked to select a problem and follow steps to solve it.

During 12 months of therapy, Robinson's group found that patients who received a placebo were 4.5 times more likely to become depressed, compared with patients who received Lexapro, and 2.2 times more likely to become depressed than patients in the therapy program.

Further analysis showed that Lexapro was significantly better than a placebo in preventing depression, while problem-solving therapy was not significantly better.

"The clinical implications of our findings are that patients who are given escitalopram or problem-solving therapy following acute stroke may be spared depression, and perhaps its adverse consequences," the researchers concluded.

One expert thinks that treating depression before it begins may be a viable option for some patients after stroke.

"Depression is a huge problem after stroke," said Dr. Argye Hillis, an associate professor of neurology at Johns Hopkins University. "This is an important study that might convince people to either start patients on preventive therapy or at least monitor very closely for depression and then start them on therapy."

Hillis noted that whether prevention is better than acute treatment isn't clear. "Based on this study, giving patients the option of preventive therapy may be the best choice for some patients," she said.

"One thing that has not been evaluated, and might be even more effective, is the combination of problem-solving therapy and medication," Hillis added.

Another expert isn't sure the results of this trial mean that all patients need to be treated for depression before it develops.

"This is a small study, and I think we need to be cautious before changing practice based on this study alone," said Dr. Eric Smith, associate director of Acute Stroke Services at Massachusetts General Hospital and Harvard Medical School.

"We need more research on treatment of post-stroke depression," Smith said. "Whether it's better to try to prevent depression, rather than treating depression after it develops, is not certain at this point," he added.

In this study, the majority of untreated patients (78 percent) never developed depression, Smith noted. "I'm not sure that my patients would want to take a brain chemical-altering drug based on a less than 50 percent chance of developing depression," he said.

"For now, I think it's most important that patients be evaluated by physical, occupational and speech therapy, as needed," Smith said. "The appropriate therapies for that individual, taking into account both the patient's individual needs and the institutional resources, can then be initiated."

More information

For more information on stroke, visit the American Stroke Association.



SOURCES: Larry B. Goldstein, M.D., professor, neurology, and director, Duke Center for Cerebrovascular Disease, Duke University Medical Center, Durham, N.C.; Argye Hillis, M.D., associate professor, neurology, Johns Hopkins University, Baltimore; Eric Smith, M.D., M.P.H., assistant professor, neurology, and associate director, Acute Stroke Services, Massachusetts General Hospital and Harvard Medical School, Boston; May 28, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Experimental Antidepressants Offer Faster Relief
2. Newer antidepressants led to less, not more, teen suicides
3. Antidepressants and painkillers - a dangerous combination
4. Antidepressants Boost GI Bleeding Risk
5. Study shows new strategy for developing antidepressants
6. Antidepressants Help HIV-Infected Patients Stick to Treatment
7. Genetics May Determine Antidepressants Effectiveness
8. Antidepressants that are more efficient and faster
9. Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine
10. As depression symptoms improve with antidepressants, hopelessness can linger
11. Only Severely Depressed Benefit From Antidepressants: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antidepressants May Prevent Depression After Stroke
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: